Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-17
    E.g., 2018-10-17

Archive Search

1 results
4:20 PM, Nov 30, 2017  |  BC Extra | Clinical News

J&J begins Phase IIb trial of mosaic HIV vaccine

found globally, unlike previous approaches that focus on viruses from specific geographical areas. The vaccine, Ad26.Mos4.HIV
sexually active women ages 18 to 35 in sub-Saharan Africa to receive intramuscular injections of Ad26.Mos4.HIV
of Technology and Harvard University. J&J is also evaluating a tetravalent form of the vaccine, Ad26.Mos4.HIV